Published in:
01-05-2016 | Editorial Commentary
Excretion of radionuclides in human breast milk after nuclear medicine examinations. Biokinetic and dosimetric data and recommendations on breastfeeding interruption
Authors:
K. Liepe, A. Becker
Published in:
European Journal of Nuclear Medicine and Molecular Imaging
|
Issue 5/2016
Login to get access
Excerpt
Since the 1990s the advantages of breastfeeding have been emphasized and the number of women who nurse their infant has increased significantly. Although women in this population are generally healthy and relatively rarely need radionuclide imaging or radionuclide therapies, the issue of radiation protection of breastfed children arises because of their higher radiosensitivity [
1]. Approximately 55 papers on excretion of radionuclides in human breast milk after radionuclide imaging or therapy have been published. Unfortunately, most of them are case reports or include only a small number of cases. In 1955 the first report was published about a breastfeeding woman after radioiodine treatment of thyrotoxicosis. This early study showed a higher concentration of radioiodine in breast milk than in plasma and investigated the risk to the infant, especially to the thyroid gland [
2]. …